Mid-basal left ventricular longitudinal dysfunction as a prognostic marker in mutated transthyretin-related cardiac amyloidosis

Abstract

Aim: Mutated transthyretin (TTRv) cardiac amyloidosis (CA) represents an uncommon form of CA. Our study aimed to assess the best echocardiographic prognostic parameter in the early stage of TTRv amyloidosis with cardiomyopathy.

Methods: In total, 99 patients with TTRv in New York Heart Association class I or II and with no clinical history of previous cardiac disease were studied. Assessment with ^99mTc-DPD whole-body scan showed CA in 46 patients. At the first medical contact, an echocardiographic examination was performed. In addition to conventional left ventricular (LV), echocardiographic measurements [ejection fraction (EF), dimensions and diastolic function, global longitudinal strain (GLS), longitudinal strain of the 4 apical segments, longitudinal strain of the 12 mid-basal segments (MBLS)] and their ratio [relative regional strain ratio (RRSR)] were obtained. Patient outcome was evaluated during a follow-up with an average duration of six years. Cardiac death and appropriate implantable cardiac defibrillator (ICD) shock were considered major events.

Results: A higher value of LV thickness, E/E’, and RRSR and lower LV volumes, EF, GLS, MBLS were observed in patients with CA than the ones with only TTRv. During follow-up (median of 7.7 years), 25 major events (23 cardiac death and 2 appropriate ICD shocks) occurred. The logistic univariate analyses showed that LV EF, LV septal thickness, E/E’, GLS, and MBLS were all predictors of cardiovascular death. In multivariate analysis, MBLS was the only independent predictor of major events. A cut off of -14 of MBLS was selected as the best value to discriminate a worse prognosis on Kaplan-Meyer analysis.

Conclusion: Longitudinal dysfunction is observed in the early stages of ATTRv amyloidosis with cardiomyopathy. Medio-basal LV longitudinal dysfunction is a strong independent echocardiographic predictor of cardiac death.

Keywords

Cardiac amyloidosis / myocardial strain imaging / prognosis

References

[1] Merlini G,Gertz MA.Amyloidosis: pathogenesis and new therapeutic options.J Clin Oncol2011;29:1924-33 PMCID:PMC3138545

[2] Sipe JD,Buxbaum JN.Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis.Amyloid2010;17:101-4

[3] Mazzeo A,Di Bella G.Transthyretin-related familial amyloid polyneuropathy (TTR-FAP): a single-center experience in sicily, an italian endemic area.J Neuromuscul Dis2015;2:S39-48 PMCID:PMC5271421

[4] Koike H.Transthyretin amyloidosis: update on the clinical spectrum, pathogenesis, and disease-modifying therapies.Neurol Ther2020;9:317-33 PMCID:PMC7500251

[5] Minutoli F,Sindoni A,Baldari S.Effectiveness of skeletal scintigraphy in transthyretin-related amyloidosis.Int J Cardiol2013;168:4988-9

[6] Di Bella G,Mazzeo A.MRI of cardiac involvement in transthyretin familial amyloid polyneuropathy.AJR Am J Roentgenol2010;195:W394-9

[7] Koike H,Murohara T.Multidisciplinary approaches for transthyretin amyloidosis.Cardiol Ther2021; PMCID:PMC8177037

[8] Phelan D,Thavendiranathan P.Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis.Heart2012;98:1442-8

[9] Senapati A,Grodin JL.Prognostic implication of relative regional strain ratio in cardiac amyloidosis.Heart2016;102:748-54

[10] Nagueh SF,Kopelen HA,Quiñones MA.Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures.J Am Coll Cardiol1997;30:1527-33

[11] Rudski LG,Afilalo J.Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography.J Am Soc Echocardiogr2010;23:685-713; quiz 786-8

[12] Perugini E,Salvi F.Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy.J Am Coll Cardiol2005;46:1076-84

[13] Di Bella G,Aquaro GD.Scar extent, left ventricular end-diastolic volume, and wall motion abnormalities identify high-risk patients with previous myocardial infarction: a multiparametric approach for prognostic stratification.Eur Heart J2013;34:104-11

[14] Bellavia D,Pellikka PA.Detection of left ventricular systolic dysfunction in cardiac amyloidosis with strain rate echocardiography.J Am Soc Echocardiogr2007;20:1194-202

[15] Bellavia D,Abraham TP.Evidence of impaired left ventricular systolic function by Doppler myocardial imaging in patients with systemic amyloidosis and no evidence of cardiac involvement by standard two-dimensional and Doppler echocardiography.Am J Cardiol2008;101:1039-45

[16] Koyama J,Falk RH.Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis.Circulation2003;107:2446-52

[17] Karavidas A,Matzaraki V.Myocardial deformation imaging unmasks subtle left ventricular systolic dysfunction in asymptomatic and treatment-naïve HIV patients.Clin Res Cardiol2015;104:975-81

[18] Di Bella G,Pingitore A.Endocardial and epicardial deformations in cardiac amyloidosis and hypertrophic cardiomyopathy.Circ J2011;75:1200-8

[19] Ternacle J,Guellich A.Causes and consequences of longitudinal LV dysfunction assessed by 2D strain echocardiography in cardiac amyloidosis.JACC Cardiovasc Imaging2016;9:126-38

[20] Siepen FAD,Voss A.Predictors of survival stratification in patients with wild-type cardiac amyloidosis.Clin Res Cardiol2018;107:158-69